Preoperative chemoradiation followed by surgical resection for resectable pancreatic cancer: A review of current results

Surgical Oncology

Volumn 20, Issue 4, 2011, Pages

  Chua, Terence C ^a,b   Saxena, Akshat ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Chemoradiation; Gemcitabine; Neoadjuvant; Pancreatectomy; Pancreatic cancer; Pancreaticoduodenectomy; Preoperative

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CISPLATIN; FLUOROURACIL; GEMCITABINE; PACLITAXEL; TEGAFUR;

CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PANCREAS CANCER; PANCREAS SURGERY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; HUMANS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PREOPERATIVE CARE; REVIEW LITERATURE AS TOPIC; TREATMENT OUTCOME;

EID: 80053644199     PISSN: 09607404     EISSN: 18793320     Source Type: Journal    
DOI: 10.1016/j.suronc.2011.05.003     Document Type: Review

References (37)

1. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M.J. Thun Cancer statistics, 2007 CA Cancer J Clin 57 1 January 1, 2007 43 66 (Pubitemid 46148091)
2. M.K. Diener, C. Heukaufer, G. Schwarzer, C.M. Seiler, G. Antes, and M.W. Buchler Pancreaticoduodenectomy (classic Whipple) versus pylorus-preserving pancreaticoduodenectomy (pp Whipple) for surgical treatment of periampullary and pancreatic carcinoma Cochrane Database Syst Rev 16 2 2008 CD006053
3. G. Butturini, D.D. Stocken, M.N. Wente, H. Jeekel, J.H.G. Klinkenbijl, and K.E. Bakkevold Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials Arch Surg 143 1 January 1, 2008 75 83 (Pubitemid 351159303)
4. C.W. Michalski, J. Kleeff, M.N. Wente, M.K. Diener, M.W. Büchler, and H. Friess Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer Br J Surg 94 3 2007 265 273 (Pubitemid 46423842)
5. Chua TC, Saxena A. Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review. J Gastrointest Surg, 2010 [Epub].
6. H. Oettle, S. Post, P. Neuhaus, K. Gellert, J. Langrehr, and K. Ridwelski Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA 297 3 January 17, 2007 267 277 (Pubitemid 46143304)
7. J.P. Neoptolemos, D.D. Stocken, C. Tudur Smith, C. Bassi, P. Ghaneh, and E. Owen Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials Br J Cancer 100 2 2009 246 250
8. J.P. Neoptolemos, D.D. Stocken, H. Friess, C. Bassi, J.A. Dunn, and H. Hickey A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 12 2004 1200 1210 (Pubitemid 38339364)
9. W.F. Regine, K.A. Winter, R.A. Abrams, H. Safran, J.P. Hoffman, and A. Konski Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial JAMA 299 9 March 5, 2008 1019 1026 (Pubitemid 351347058)
10. J.P. Neoptolemos Clinical evidence does not support the use of adjuvant radiotherapy in pancreatic cancer Nat Clin Pract Oncol 5 8 2008 431
11. D.B. Evans, T.A. Rich, D.R. Byrd, K.R. Cleary, J.H. Connelly, and B. Levin Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas Arch Surg 127 11 1992 1335 1339
12. M. Francoise, G. Nicolas, S. Jean-Yves, B. Nadine, Y. Marc, and S. Denis Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: the French SFRO-FFCD 97-04 Phase II trial Int J Radiat Oncol Biol Phys 65 5 2006 1471 1478
13. T.M. Breslin, K.R. Hess, D.B. Harbison, M.E. Jean, K.R. Cleary, and A.P. Dackiw neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration Ann Surg Oncol 8 2 2001 123 132 (Pubitemid 32199408)
14. K.M. Brown, V. Siripurapu, M. Davidson, S.J. Cohen, A. Konski, and J.C. Watson Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma Am J Surg 195 3 2008 318 321 (Pubitemid 351625118)
15. D.B. Evans, G.R. Varadhachary, C.H. Crane, C.C. Sun, J.E. Lee, and P.W.T. Pisters Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head J Clin Oncol 26 21 July 20, 2008 3496 3502
16. H.G.K. Matthew, W.T.P. Peter, B.E. Douglas, C.S. Charlotte, E.L. Jeffrey, and B.F. Jason Borderline resectable pancreatic cancer: the importance of this emerging stage of disease J Am Coll Surgeons 206 5 2008 833 846
17. V.K. Mehta, G. Fisher, J.A. Ford, J.C. Poen, M.A. Vierra, and H. Oberhelman Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas J Gastrointest Surg 5 2001 27 35 (Pubitemid 33651235)
18. H. Takahashi, H. Ohigashi, O. Ishikawa, H. Eguchi, K. Gotoh, and T. Yamada Serum CA19-9 alterations during preoperative gemcitabine-based chemoradiation therapy for resectable invasive ductal carcinoma of the pancreas as an indicator for therapeutic selection and survival Ann Surg 251 2010 461 469
19. S. Takai, S. Satoi, H. Yanagimoto, H. Toyokawa, K. Takahashi, and N. Terakawa Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer Pancreas 36 2008 e26 e32
20. O. Turrini, F. Viret, L. Moureau-Zabotto, J. Guiramand, V. Moutardier, and B. Lelong Neoadjuvant 5 fluorouracil-cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: a ten-year single institution experience Oncology 76 2009 413 419
21. G.R. Varadhachary, R.A. Wolff, C.H. Crane, C.C. Sun, J.E. Lee, and P.W.T. Pisters Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head J Clin Oncol 26 21 July 20, 2008 3487 3495
22. P. Vento, H. Mustonen, T. Joensuu, P. Kärkkäinen, E. Kivilaakso, and T. Kiviluoto Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer World J Gastroenterol 13 21 2007 2945 2951 (Pubitemid 47033753)
23. R.R. White, H.I. Hurwitz, M.A. Morse, C. Lee, M. Anscher, and E.K. Paulson Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas Ann Surg Oncol 8 10 2001 758 765 (Pubitemid 34003323)
24. J. Landry, P.J. Catalano, C. Staley, W. Harris, J. Hoffman, and M. Talamonti Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma J Surg Oncol 101 7 2010 587 592
25. F.A. Calvo, R. Matute, J.L. Garcia-Sabrido, M. Gomez-Espi, N.E. Martinez, and M.A. Lozano Neoadjuvant chemoradiation with tegafur in cancer of the pancreas: initial analysis of clinical tolerance and outcome Am J Clin Oncol 27 2004 343 349 (Pubitemid 39045243)
26. P.W.T. Pisters, R.A. Wolff, N.A. Janjan, K.R. Cleary, C. Charnsangavej, and C.N. Crane Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome J Clin Oncol 20 2002 2537 2544 (Pubitemid 34525741)
27. H.J. Wanebo, A.S. Glicksman, M.P. Vezeridis, J. Clark, L. Tibbetts, and R.J. Koness Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer Arch Surg 135 2000 81 87 (Pubitemid 30043986)
28. M. Talamonti, W. Small Jr., M.F. Mulcahy, J.D. Wayne, V. Attaluri, and L.M. Colletti A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma Ann Surg Oncol 13 2 2006 150 158 (Pubitemid 43157408)
29. J.H. Klinkenbijl, J. Jeekel, T. Sahmoud, R. van Pel, M.L. Couvreur, and C.H. Veenhof Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group Ann Surg 230 6 1999 776 782
30. S.R. Grobmyer, F.M. Pieracci, P.J. Allen, M.F. Brennan, and D.P. Jaques Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system J Am Coll Surgeons 204 3 2007 356 364 (Pubitemid 46283487)
31. D.D. Stocken, M.W. Buchler, C. Dervenis, C. Bassi, H. Jeekel, and J.H.G. Klinkenbijl Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer Br J Cancer 92 8 2005 1372 1381 (Pubitemid 40705002)
32. G.R. Varadhachary, E.P. Tamm, J.L. Abbruzzese, H.Q. Xiong, C.H. Crane, and H. Wang Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy Ann Surg Oncol 13 8 2006 1035 1046 (Pubitemid 44337962)
33. M.A. Khalifa, V. Maksymov, and C. Rowsell Retroperitoneal margin of the pancreaticoduodenectomy specimen: anatomic mapping for the surgical pathologist Virchows Arch. 454 2 2009 125 131
34. D.K. Chang, A.L. Johns, N.D. Merrett, A.J. Gill, E.K. Colvin, and C.J. Scarlett Margin clearance and outcome in resected pancreatic cancer J Clin Oncol 27 17 June 10, 2009 2855 2862
35. A. Gill, A. Johns, R. Eckstein, J. Samra, A. Kaufman, and D. Chang Synoptic reporting improves histopathological assessment of pancreatic resection specimens Pathology 41 2009 161 167
36. T.S. Hong, D.L. Craft, F. Carlsson, and T.R. Bortfeld Multicriteria optimization in intensity-modulated radiation therapy treatment planning for locally advanced cancer of the pancreatic head Int J Radiat Oncol Biol Phys. 72 4 2008 1208 1214
37. K.R. Kozak, L.A. Kachnic, J. Adams, E.M. Crowley, B.M. Alexander, and H.J. Mamon Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatment Int J Radiat Oncol Biol Phys. 68 5 2007 1557 1566 (Pubitemid 47176818)